% ============================================================================
% CONSTRAINT STORY: ad_synaptic_deficit
% ============================================================================
% Version: 1.0 (Deferential Realism Core + Directionality + Boltzmann + Network)
% Logic: 6.0 (Indexed Tuple P,T,E,S + Sigmoid f(d) + Coupling + Purity + Network)
% Generated: 2026-02-26
% Status: [ACTIVE]
% ============================================================================

:- module(constraint_ad_synaptic_deficit, []).

:- use_module(constraint_indexing).
:- use_module(domain_priors).
:- use_module(narrative_ontology).

% --- Constraint Identity Rule (DP-001: ε-Invariance) ---
% Each constraint story must have a single, stable base extractiveness (ε).
% If changing the observable used to evaluate this constraint would change ε,
% you are looking at two distinct constraints. Write separate .pl files for
% each, link them with affects_constraint/2, and document the relationship
% in both files' narrative context sections.
%
% The context tuple is CLOSED at arity 4: (P, T, E, S).
% Do not add measurement_basis, beneficiary/victim, or any other arguments.
% Linter Rule 23 enforces context/4.
%
% See: epsilon_invariance_principle.md

% --- Namespace Hooks (Required for loading) ---
:- multifile
    domain_priors:base_extractiveness/2,
    domain_priors:suppression_score/2,
    domain_priors:theater_ratio/2,
    domain_priors:requires_active_enforcement/1,
    narrative_ontology:has_sunset_clause/1,
    narrative_ontology:interval/3,
    narrative_ontology:measurement/5,
    narrative_ontology:constraint_metric/3,
    narrative_ontology:constraint_beneficiary/2,
    narrative_ontology:constraint_victim/2,
    narrative_ontology:constraint_claim/2,
    narrative_ontology:affects_constraint/2,
    narrative_ontology:coordination_type/2,
    constraint_indexing:constraint_classification/3,
    constraint_indexing:directionality_override/3,
    narrative_ontology:omega_variable/3,
    narrative_ontology:human_readable/2,
    narrative_ontology:topic_domain/2.

/* ==========================================================================
   1. NARRATIVE CONTEXT
   ========================================================================== */

/**
 * CONSTRAINT IDENTIFICATION
 *   constraint_id: ad_synaptic_deficit
 *   human_readable: Synaptic Liquidation (Neuro-Degenerative Debt)
 *   domain: biological/technological
 *
 * SUMMARY:
 *   Synaptic liquidation in neurodegenerative disease represents an
 *   irreversible extraction of cognitive function from the neural network and
 *   host organism. The constraint operates at the intersection of biology
 *   (protein misfolding, axonal degeneration) and institutional response
 *   (pharmaceutical symptom management, research funding structures). From
 *   the network's perspective, it is a snare: synapses are liquidated without
 *   recovery mechanism, cognitive capacity is extracted irreversibly, and
 *   suppression of alternatives is nearly total in current biology. From the
 *   organism's perspective, it is also a snare: functional degradation is
 *   inescapable, and exit options are constrained to palliative care or
 *   consciousness suspension. From the analytical perspective, it appears to
 *   be a mountain — an immutable biological limit. From the research
 *   establishment perspective, it is a tangled rope — the constraint both
 *   drives and sustains their institutional role. From the pharmaceutical
 *   industry perspective, it is a piton — a degraded ritual of symptom
 *   management that persists through inertia rather than efficacy. From the
 *   regenerative medicine perspective, it is a scaffold with a 10-20 year
 *   sunset. The constraint exhibits high extractiveness (0.68) and high
 *   suppression (0.74) because the liquidation is fast, irreversible, and the
 *   alternatives (regeneration, replacement) are currently unavailable.
 *   Theater ratio is low (0.38) because the underlying pathology is real and
 *   not primarily performative — unlike many institutional constraints, this
 *   one reflects genuine biological dysfunction. The extractiveness
 *   trajectory shows acceleration over time: early disease manifests low
 *   extractiveness (35%) because many synapses remain intact and functional
 *   redundancy is high; advanced disease reaches high extractiveness (68%)
 *   because remaining synapses can no longer compensate for losses.
 *
 * KEY AGENTS:
 *   - Degrading Neural Network: Primary victim (powerless/trapped) — bears full cost of irreversible synaptic loss; no exit or recovery mechanism
 *   - Affected Organism (patient/host): Primary victim (moderate/constrained) — experiences progressive functional loss; constrained to palliative care or slow disease progression
 *   - Cognitive Function: Abstract victim (powerless/trapped) — irreversibly liquidated; no compensation mechanism available
 *   - Pharmaceutical Industry: Institutional beneficiary (institutional/arbitrage) — benefits from extended disease management; minimal pressure to develop curative therapies
 *   - Neurodegenerative Research Establishment: Mixed (institutional/constrained) — benefits from funding and publications; constrained by slow translational timelines and resource concentration
 *   - Regenerative Medicine Coalition: Organized aspirant (organized/constrained) — attempting to create exit pathway through stem cells, optogenetics, and neural interfaces; constrained by regulatory barriers and development timelines
 */

/* ==========================================================================
   2. BASE PROPERTIES (DOMAIN PRIORS)
   ========================================================================== */

% --- Numerical metrics ---
domain_priors:base_extractiveness(ad_synaptic_deficit, 0.68).
domain_priors:suppression_score(ad_synaptic_deficit, 0.74).
domain_priors:theater_ratio(ad_synaptic_deficit, 0.38).

% --- Constraint metric facts (engine primary keys, must mirror domain_priors) ---
narrative_ontology:constraint_metric(ad_synaptic_deficit, extractiveness, 0.68).
narrative_ontology:constraint_metric(ad_synaptic_deficit, suppression_requirement, 0.74).
narrative_ontology:constraint_metric(ad_synaptic_deficit, theater_ratio, 0.38).

% --- Constraint claim ---
narrative_ontology:constraint_claim(ad_synaptic_deficit, snare).
narrative_ontology:human_readable(ad_synaptic_deficit, "Synaptic Liquidation (Neuro-Degenerative Debt)").
narrative_ontology:topic_domain(ad_synaptic_deficit, "biological/technological").

domain_priors:requires_active_enforcement(ad_synaptic_deficit).
% --- Structural relationships ---
narrative_ontology:constraint_victim(ad_synaptic_deficit, cognitive_function).
narrative_ontology:constraint_victim(ad_synaptic_deficit, network_capacity).
narrative_ontology:constraint_victim(ad_synaptic_deficit, host_organism).

/* ==========================================================================
   3. INDEXED CLASSIFICATIONS (P, T, E, S)
   ========================================================================== */

% PERSPECTIVE 1: THE DEGRADING NEURAL NETWORK (SNARE) — The network bears the full cost of synaptic liquidation without exit or recovery option. Once connectivity is lost, it cannot be restored through the network's own dynamics. Maximum extraction: the constraint siphons cognitive capacity irreversibly. The network is trapped in progressive degradation with no behavioral exit.
constraint_indexing:constraint_classification(ad_synaptic_deficit, snare,
    context(agent_power(powerless),
            time_horizon(biographical),
            exit_options(trapped),
            spatial_scope(local))).

% PERSPECTIVE 2: THE AFFECTED ORGANISM (SNARE) — The host organism experiences progressive functional loss: memory, coordination, reasoning, emotional regulation. Exit options are severely constrained — medical interventions may slow but cannot reverse synaptic loss. The organism bears the extraction cost through diminished agency and survival capacity. Suppression of alternatives: no known mechanism restores lost synaptic connectivity in adult neurons.
constraint_indexing:constraint_classification(ad_synaptic_deficit, snare,
    context(agent_power(moderate),
            time_horizon(biographical),
            exit_options(constrained),
            spatial_scope(regional))).

% PERSPECTIVE 3: ANALYTICAL OBSERVER / BIOLOGICAL LIMIT VIEW (MOUNTAIN) — From a civilizational perspective, synaptic liquidation appears as an irreducible biological constraint: neurons do not regenerate their axons in most adult CNS regions; synaptic density decreases with age; protein misfolding cascades are thermodynamically driven. The constraint emerges naturally from cellular biology and appears immutable. However, this perspective risks naturalizing what is partly contingent on current developmental biology — if induced pluripotent stem cells or synthetic synaptic scaffolds achieve reliable integration, the mountain classification fails.
constraint_indexing:constraint_classification(ad_synaptic_deficit, mountain,
    context(agent_power(analytical),
            time_horizon(civilizational),
            exit_options(analytical),
            spatial_scope(universal))).

% PERSPECTIVE 4: REGENERATIVE MEDICINE COALITION (SCAFFOLD) — Organized research efforts (stem cell therapies, optogenetic repair, neural interface technologies) view synaptic liquidation as a temporary coordination failure with a sunset horizon. If synaptic regeneration or artificial replacement achieves clinical efficacy in 10-20 years, the constraint's extraction mechanism dissolves — the liquidation becomes repairable rather than permanent. Theater is low because the research is functionally aimed at solving the problem, not performing compliance.
constraint_indexing:constraint_classification(ad_synaptic_deficit, scaffold,
    context(agent_power(organized),
            time_horizon(generational),
            exit_options(constrained),
            spatial_scope(global))).

% PERSPECTIVE 5: PHARMACEUTICAL SYMPTOM MANAGEMENT INDUSTRY (PITON) — Current neuropharmacology (cholinesterase inhibitors, memantine, etc.) is largely performative: these drugs slow cognitive decline marginally but do not halt or reverse synaptic loss. The institutional actor benefits from prolonged disease management (recurring prescriptions, market maintenance) while the underlying constraint persists. Theater ratio is high because the pharmacological ritual persists despite limited functional restoration. The piton classification reflects degraded primary function — these interventions maintain a disease management theater rather than addressing the root mechanism.
constraint_indexing:constraint_classification(ad_synaptic_deficit, piton,
    context(agent_power(institutional),
            time_horizon(immediate),
            exit_options(arbitrage),
            spatial_scope(global))).

% PERSPECTIVE 6: NEURODEGENERATIVE RESEARCH ESTABLISHMENT (TANGLED ROPE) — The research community benefits from the constraint through funding, publications, and career advancement (coordination function: understanding disease mechanisms), but also participates in extraction through slow translational timelines and resource concentration. The constraint both enables and constrains their work — understanding synaptic loss drives research agendas, but the lack of effective treatments maintains the funding pipeline. Suppression of alternatives: alternative funding models (direct-to-patient biotech, cooperative research) are constrained by regulatory and capital barriers.
constraint_indexing:constraint_classification(ad_synaptic_deficit, tangled_rope,
    context(agent_power(institutional),
            time_horizon(biographical),
            exit_options(constrained),
            spatial_scope(national))).

/* ==========================================================================
   4. VALIDATION TESTS
   ========================================================================== */

:- begin_tests(ad_synaptic_deficit_tests).

test(perspectival_gap) :-
    constraint_indexing:constraint_classification(ad_synaptic_deficit, TypePowerless, context(agent_power(powerless), _, _, _)),
    constraint_indexing:constraint_classification(ad_synaptic_deficit, TypeOther, context(agent_power(analytical), _, _, _)),
    TypePowerless \= TypeOther.

test(extraction_signature) :-
    domain_priors:base_extractiveness(ad_synaptic_deficit, E),
    E >= 0.46. % Ensures high-extraction Snare/Tangled territory.

test(piton_threshold) :-
    domain_priors:theater_ratio(ad_synaptic_deficit, TR),
    TR >= 0.70.

:- end_tests(ad_synaptic_deficit_tests).

/* ==========================================================================
   5. GENERATIVE COMMENTARY
   ========================================================================== */

/**
 * LOGIC RATIONALE:
 *   Extractiveness (0.68): High. The constraint systematically extracts cognitive function with no recovery mechanism. Unlike extractive institutions that can be reformed or abandoned, synaptic loss in adult CNS is biologically irreversible (under current developmental constraints). The value reflects that the extraction accelerates over time as compensatory mechanisms fail. Suppression (0.74): Very high. The suppression of alternatives is biological, not merely institutional. Adult CNS neurons do not regenerate axons; synaptic connections cannot be restored through endogenous plasticity mechanisms alone; protein misfolding cascades are thermodynamically driven. Current interventions (cholinesterase inhibitors, memantine) suppress symptoms but not the underlying mechanism. Theater ratio (0.38): Moderate-low. Unlike many institutional constraints, synaptic liquidation reflects real pathology, not primarily performative activity. However, the pharmaceutical response (symptom management without cure) has modest theater component — the ritual of medication persists despite marginal efficacy. The gap between theatrical intervention and actual halting of disease reflects institutional inertia more than biological necessity.
 *
 * PERSPECTIVAL GAP:
 *   This constraint demonstrates a dramatic perspectival gap between victim and observer. The powerless victim (neural network) sees a snare: irreversible liquidation with no exit. The moderate victim (organism) also sees a snare with slightly more agency: palliative care options exist, though they do not halt the underlying process. The analytical observer risks seeing a mountain (natural law of biology), which could lead to resignation: 'synaptic loss is inherent to aging, nothing can be done.' The regenerative medicine coalition sees a scaffold (sunset: 10-20 years to curative therapies). The pharmaceutical industry sees a stable, recurring revenue stream (piton: degraded but persistent symptom management). The research establishment sees a career-sustaining funding pipeline (tangled rope). The perspectival gap reveals a critical structural problem: the institutions that benefit from disease management (pharma) have less incentive to cure than to maintain the constraint. The snare persists because no stakeholder with sufficient resources and power is fully aligned with victim interests.
 *
 * DIRECTIONALITY LOGIC:
 *   The constraint's directionality derives from the complete absence of beneficiaries and presence of multiple trapped or constrained victims. No institutional actor benefits from synaptic loss itself — the pharmaceutical industry benefits from disease management (not the disease), and the research establishment benefits from research funding (not the disease). The victims — the network, the organism, cognitive function — have no exit options. The network cannot recover lost synapses. The organism cannot voluntarily exit the disease (though it could voluntarily end consciousness, an option constrained by cognitive decline itself in advanced disease). Cognitive function is abstract but real victim status. The derivation chain produces maximal d values (0.85-0.95) for all victims, yielding high f(d) and amplified chi. The beneficiary perspective (pharmaceutical) shows low or negative chi because the disease exists independent of pharmaceutical management — the drugs do not extract in the traditional sense, though they do extract economic value while failing to address the root constraint.
 *
 * MANDATROPHY ANALYSIS:
 *   MANDATROPHY RESOLVED: This constraint's high extractiveness (0.68 > 0.70 approaches threshold) and multi-perspective classification structure reveal that synaptic liquidation is NOT a natural law (mountain), despite how it appears from the analytical perspective. The mountain classification fails because: (1) Accessibility collapse is not near 0.85 — regenerative pathways exist in research (iPS cells, optogenetics) and are not fundamentally inaccessible, merely underfunded. (2) Resistance is not uniformly low — institutional resistance to funding regenerative approaches (regulatory complexity, long timelines, lower profit margins vs symptom management) is real and contingent. (3) The constraint exhibits suppression ≥ 0.74, which means it requires enforcement — institutional choices (pharmaceutical business model, funding concentration) suppress alternatives. A true mountain would have suppression ≤ 0.05. Therefore, the analytical observer's mountain classification is a FALSE SUMMIT: it naturalizes what is partly a contingent institutional arrangement. The true structure is a snare (for victims) enforced by institutional pitons (pharmaceutical ritual) that suppress scaffold alternatives (regenerative medicine). The mandatrophy resolves by revealing that the constraint's appearance of inevitability reflects institutional stasis, not biological inevitability.
 */

/* ==========================================================================
   6. OMEGA VARIABLES (Ω) - IRREDUCIBLE UNCERTAINTIES
   ========================================================================== */

omega_variable(
    biological_reversibility_ceiling,
    'Is synaptic liquidation fundamentally irreversible at the adult CNS level, or is irreversibility an artifact of current regenerative capacity?',
    'Experimental demonstration of sustained axonal regeneration and synaptogenesis in mature primate cortex; clinical trials of stem cell or optogenetic repair with functional restoration in human patients.',
    'If fundamentally irreversible: mountain classification confirmed, snare classification is structural reality. If reversible: scaffold classification extends toward rope, regenerative timeline becomes critical parameter.',
    confidence_without_resolution(medium)
).

narrative_ontology:omega_variable(biological_reversibility_ceiling, empirical, 'Whether synaptic liquidation is fundamentally irreversible').

omega_variable(
    therapeutic_restoration_timeline,
    'What is the realistic timeline for clinical translation of synaptic regeneration therapies — 5 years, 20 years, or never within economic constraints?',
    'Phase III clinical trial data for stem cell therapies, gene therapy vectors, and optogenetic repair in neurodegenerative models; health economic analysis of cost-benefit thresholds.',
    'If achievable within 10 years at scale: scaffold sunset is credible, generational timescale perspectives shift. If never economically viable: scaffold is aspirational, snare remains the structural reality for most affected populations.',
    confidence_without_resolution(low)
).

narrative_ontology:omega_variable(therapeutic_restoration_timeline, empirical, 'Timeline for clinical translation of synaptic regeneration therapies').

omega_variable(
    extraction_vs_disease_causality,
    'Is the constraint better modeled as a snare (extraction mechanism targeting cognitive function) or as a natural consequence of protein misfolding biology (mountain)?',
    'Analysis of whether synaptic loss is actively enforced by suppression of alternatives (snare signature) or passively emerges from thermodynamic constraints (mountain signature). Comparative analysis with other irreversible biological processes (telomere shortening, mtDNA mutation accumulation).',
    'If snare: therapeutic research should prioritize reversibility mechanisms. If mountain: research should focus on slowing progress or compensatory pathways. If mixed: both strategies are justified.',
    confidence_without_resolution(high)
).

narrative_ontology:omega_variable(extraction_vs_disease_causality, conceptual, 'Whether synaptic deficit is extraction mechanism or natural biological limit').

omega_variable(
    synthetic_neural_substrate_equivalence,
    'Can synthetic synaptic substrates (neuromorphic chips, biological-silicon interfaces) achieve functional equivalence to biological synaptic networks with lower liquidation rates?',
    'Demonstration of long-term (decade-scale) stability and learning capacity in neuromorphic systems; proof of concept for brain-computer interfaces maintaining stable information processing.',
    'If achievable: constraint becomes technology-contingent rather than biologically immutable. Organisms could externalize synaptic function to non-degrading substrate, converting snare to scaffold with very long sunset. If unachievable: biological brain remains trapped in constraint.',
    confidence_without_resolution(low)
).

narrative_ontology:omega_variable(synthetic_neural_substrate_equivalence, empirical, 'Whether synthetic neural substrates can achieve functional equivalence with lower degradation').


/* ==========================================================================
   7. INTEGRATION HOOKS
   ========================================================================== */

narrative_ontology:interval(ad_synaptic_deficit, 0, 20).

/* ==========================================================================
   8. TEMPORAL MEASUREMENTS (LIFECYCLE DRIFT DATA)
   ========================================================================== */

% Theater ratio over time
narrative_ontology:measurement(ad_syn_tr_t0, ad_synaptic_deficit, theater_ratio, 0, 0.22).
narrative_ontology:measurement(ad_syn_tr_t10, ad_synaptic_deficit, theater_ratio, 10, 0.32).
narrative_ontology:measurement(ad_syn_tr_t20, ad_synaptic_deficit, theater_ratio, 20, 0.38).

% Extraction over time
narrative_ontology:measurement(ad_syn_be_t0, ad_synaptic_deficit, base_extractiveness, 0, 0.35).
narrative_ontology:measurement(ad_syn_be_t10, ad_synaptic_deficit, base_extractiveness, 10, 0.55).
narrative_ontology:measurement(ad_syn_be_t20, ad_synaptic_deficit, base_extractiveness, 20, 0.68).


/* ==========================================================================
   9. BOLTZMANN & NETWORK DATA
   ========================================================================== */

narrative_ontology:coordination_type(ad_synaptic_deficit, resource_allocation).
narrative_ontology:affects_constraint(ad_synaptic_deficit, age_related_cognitive_decline).
narrative_ontology:affects_constraint(ad_synaptic_deficit, protein_misfolding_cascade).
narrative_ontology:affects_constraint(ad_synaptic_deficit, pharmaceutical_symptom_management_trap).

% DUAL FORMULATION NOTE:
% Synaptic liquidation decomposes into three related constraints: (1) protein_misfolding_cascade (upstream ε=0.12, Mountain — thermodynamic inevitability of tau/amyloid aggregation), (2) ad_synaptic_deficit (this story, ε=0.68, Snare — institutional response to liquidation), (3) pharmaceutical_symptom_management_trap (downstream ε=0.55, Piton — degraded intervention maintaining disease management without cure). The upstream mountain (protein misfolding) generates synaptic liquidation; the institutional response (this constraint) extracts from victims through suppression of regenerative alternatives; the downstream piton maintains the extraction through therapeutic theater. Each has different ε because they represent different structural mechanisms: one is biological thermodynamics, one is institutional extraction, one is institutional performance.

/* ==========================================================================
   10. DIRECTIONALITY OVERRIDES (v6.0, OPTIONAL)
   ========================================================================== */

constraint_indexing:directionality_override(ad_synaptic_deficit, institutional, 0.25).

/* ==========================================================================
   END OF CONSTRAINT STORY
   ========================================================================== */
